Full text is available at the source.
Carboxypeptidase M Expressed by Human Bone Marrow Cells Cleaves the C-Terminal Lysine of Stromal Cell-Derived Factor-1α: Another Player in Hematopoietic Stem/Progenitor Cell Mobilization?
Bone marrow cells produce carboxypeptidase M that trims stromal cell factor-1alpha, possibly affecting stem cell movement
AI simplified
Abstract
CPM transcript is expressed by various hematopoietic and stromal cells, including bone marrow and mobilized peripheral blood CD34(+) cells.
- Granulocyte-colony-stimulating factor (G-CSF) significantly increases CPM expression at both gene and protein levels in mononuclear and polymorphonuclear cells.
- Recombinant CPM rapidly cleaves full-length SDF-1alpha, removing its C-terminal lysine and producing des-lys SDF-1alpha.
- Treatment with CPM reduces the in vitro chemotaxis of hematopoietic stem/progenitor cells (HSPC).
- The reduced chemotaxis effect is preserved when CPM is treated with the carboxypeptidase inhibitor dl-2-mercaptomethyl-3-guanidino-ethylthiopropanoic acid.
- Cleavage of SDF-1alpha by CPM may attenuate chemotactic responses and could aid in G-CSF-induced mobilization of HSPC from bone marrow.
AI simplified